查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1697391

全球人工器官市场－2025年至2030年的预测

Global Artificial Organ Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球人工器官市场预计将从 2025 年的 46.91 亿美元成长到 2030 年的 66.87 亿美元，预测期内复合年增长率高达 7.35%。

由于 3D 列印、奈米技术和先进人工智慧等趋势，全球人工器官市场正在扩大。这些技术使得能够创建具有复杂结构和高生物相容性的患者特定器官。奈米材料越来越多地被采用来提高产品性能和耐用性。人工智慧将用于设计器官，将功能与患者需求结合，以改善治疗并提高成功率。此外，器官捐赠者的短缺也促使等待移植的患者考虑人工器官，从而促进其未来的广泛使用。

推动人造器官市场成长的因素：

  • 慢性病盛行率上升：慢性病盛行率上升正在推动全球人工器官市场的发展，人工器官为器官功能障碍患者提供了潜在的解决方案。人工器官可以作为器官移植前的临时支撑或作为终身替代品。在美国，心臟病、癌症、中风、慢性呼吸系统疾病和糖尿病是主要的死亡原因，2023 年分别导致 702,880 人死亡、608,371 人死亡、165,393 人死亡、147,382 人死亡和 101,209 人死亡。
  • 老龄人口增加：全球老龄人口增加正在刺激人工器官市场的发展。与老龄化相关的疾病，如心血管疾病、肾臟疾病、呼吸系统疾病和神经退化性疾病，会随着器官功能的下降而导致器官衰竭。美国50岁及以上人口预计将从2020年的1.3725亿增加到2050年的2.2113亿，增幅为61.11%；慢性病患病率预计将从2020年的7152.2万人增加到2050年的1.4266亿，增幅为99.5%。

人造器官市场地理展望

  • 北美：北美凭藉其强大的医疗保健基础设施、先进技术的高度采用以及庞大的患者群体占据市场主导地位。例如，美国医疗保健支出到2023年将成长7.5%，达到4.9兆美元，人均14,570美元。
  • 欧洲：欧洲人口老化，医疗保健体系强大，并得到政府重视研究、创新和发展的措施的支持，使得人工器官的使用变得十分成熟。该地区老年人口预计将大幅成长，从 2019 年的 9,050 万人增至 2050 年的 1.298 亿人。
  • 亚太地区：由于经济转型、老化社会慢性病增加、政府对医疗设施支出增加以及公众意识提升，预计亚太地区的人工器官市场将显着增长。
  • 中东和非洲：医疗保健基础设施的投资、政府资金的增加以及政府改善医疗保健管道的倡议预计将加强中东和非洲的人工器官市场。
  • 南美：南美地区的人造器官产品销售量正在增加。由于慢性病盛行率不断上升、人们意识不断增强以及医疗保健领域的进步，该地区正在人工器官领域逐步建立品牌股权。

为什么要购买这份报告？

  • 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的历史资料与预测
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争定位、策略和市场占有率分析
  • 收益成长和预测包括国家在内的细分市场和地区分析
  • 公司概况（特别是主要趋势）

人造器官市场细分为：

依产品类型

  • 人工心臟
  • 人工肾
  • 人工肺
  • 人工肝
  • 人工胰臟
  • 人工电子耳
  • 其他类型

依器官类型

  • 永久性人造器官
  • 临时人工器官

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
  • 中东 中东和非洲
  • 沙乌地阿拉伯
  • UAE
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 台湾
  • 澳洲
  • 其他的

目录

第一章 引言

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

5. 全球人工器官市场（依产品类型）

  • 介绍
  • 人工心臟
  • 人工肾
  • 人工肺
  • 人工肝
  • 人工胰臟
  • 人工电子耳
  • 其他类型

6. 全球人工器官市场（依器官类型）

  • 介绍
  • 永久性人造器官
  • 临时人工器官

7. 全球人造器官市场（按地区）

  • 介绍
  • 北美洲
    • 依产品类型
    • 依器官类型
    • 按国家
  • 南美洲
    • 依产品类型
    • 依器官类型
    • 按国家
  • 欧洲
    • 依产品类型
    • 依器官类型
    • 按国家
  • 中东和非洲
    • 依产品类型
    • 依器官类型
    • 按国家
  • 亚太地区
    • 依产品类型
    • 依器官类型
    • 按国家

第八章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第九章 公司简介

  • Baxter
  • Boston Scientific Corporation
  • Asahi Kasei Medical
  • Medtronic PLC
  • Abiomed
  • SynCardia Systems
  • Carmat
  • Getinge
  • Terumo
  • BiVACOR Inc
简介目录
Product Code: KSI061617306

The global artificial organ market is set to witness robust growth at a CAGR of 7.35% during the forecast period to be worth US$6.687 billion in 2030 from US$4.691 billion in 2025.

The global artificial organs market is expanding, driven by trends like 3D printing, nanotechnology, and advanced AI. These technologies enable the creation of patient-specific organs with intricate structures and high biocompatibility. Nanomaterials are increasingly incorporated to enhance product performance and durability. AI is used in organ design and functionality is integrated with patient needs for improved treatment and higher success rates. Furthermore, the shortage of organ donors encourages patients awaiting transplants to consider artificial organs, boosting their future popularity.

Artificial Organ Market Growth Drivers:

  • Increasing Prevalence of Chronic Diseases: The rising incidence of chronic illnesses is driving the global artificial organs market, as these devices offer potential solutions for patients with organ dysfunction. Artificial organs can serve as temporary support before organ transplantation or as lifelong replacements. In America, heart disease, cancer, stroke, chronic lower respiratory diseases, and diabetes are leading causes of death, accounting for 702,880, 608,371, 165,393, 147,382, and 101,209 deaths, respectively, in 2023.
  • Rising Aging Population: The growing global aging population is fueling the development of the artificial organ market. Age-related diseases, such as cardiovascular, kidney, respiratory, and neurodegenerative conditions, along with declining organ function, can lead to organ failure. In the US, the population aged 50 and older is projected to increase by 61.11%, from 137.25 million in 2020 to 221.13 million by 2050, and the prevalence of chronic illness is expected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050.

Artificial Organ Market Geographical Outlook:

  • North America: North America is a dominant market player due to its strong healthcare infrastructure, high adoption of advanced technologies, and a large patient population. For example, healthcare expenses in the US increased by 7.5% to $4.9 trillion in 2023, reaching $14,570 per person.
  • Europe: Europe is well-established in the use of artificial organs due to its aging population and a robust healthcare system supported by government initiatives that emphasize research, innovative technologies, and development. The region's older population is projected to rise significantly, from 90.5 million in 2019 to 129.8 million by 2050.
  • Asia-Pacific: The Asia-Pacific region is expected to experience substantial growth in the artificial organ market due to economic transformations, an increasing prevalence of chronic diseases among the aging population, rising government expenditures on healthcare facilities, and improved public awareness.
  • Middle East and Africa: The artificial organ market in the Middle East and Africa is expected to strengthen, driven by investments in healthcare infrastructure, increasing government funding, and government efforts to improve healthcare access.
  • South America: The South American region is experiencing rising sales of artificial organ products. With the increasing incidence of chronic diseases, growing awareness, and improvements in the health sector, the region is gradually establishing brand equity in the artificial organ sector.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Artificial Organ Market is analyzed into the following segments:

By Product Type

  • Artificial Heart
  • Artificial Kidney
  • Artificial Lungs
  • Artificial Liver
  • Artificial Pancreas
  • Cochlear Implants
  • Other Types

By Organ Type

  • Permanent Artificial Organs
  • Temporary Artificial Organs

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL ARTIFICIAL ORGAN MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Artificial Heart
  • 5.3. Artificial Kidney
  • 5.4. Artificial Lungs
  • 5.5. Artificial Liver
  • 5.6. Artificial Pancreas
  • 5.7. Cochlear Implants
  • 5.8. Other Types

6. GLOBAL ARTIFICIAL ORGAN MARKET BY ORGAN TYPE

  • 6.1. Introduction
  • 6.2. Permanent Artificial Organ
  • 6.3. Temporary Artificial Organ

7. GLOBAL ARTIFICIAL ORGAN MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Product Type
    • 7.2.2. By Organ Type
    • 7.2.3. By Country
      • 7.2.3.1. USA
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Product Type
    • 7.3.2. By Organ Type
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Product Type
    • 7.4.2. By Organ Type
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Spain
      • 7.4.3.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Product Type
    • 7.5.2. By Organ Type
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Product Type
    • 7.6.2. By Organ Type
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. Japan
      • 7.6.3.3. India
      • 7.6.3.4. South Korea
      • 7.6.3.5. Taiwan
      • 7.6.3.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Baxter
  • 9.2. Boston Scientific Corporation
  • 9.3. Asahi Kasei Medical
  • 9.4. Medtronic PLC
  • 9.5. Abiomed
  • 9.6. SynCardia Systems
  • 9.7. Carmat
  • 9.8. Getinge
  • 9.9. Terumo
  • 9.10. BiVACOR Inc